Evidence map›Paper›PMID 20014386›Full record

ArticleHippocampus2011

Phosphacan and receptor protein tyrosine phosphatase β expression mediates deafferentation-induced synaptogenesis.

Janna L Harris, Thomas M Reeves, Linda L Phillips

Abstract read
In one paragraph

Article in Hippocampus, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Effects of chemogenetic virus injection and clozapine administration in spinal cord injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Janna L HarrisDepartment of Anatomy and Neurobiology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.
Thomas M Reeves
Linda L Phillips
Virginia Commonwealth University Medical Center · US

Funding

VCU Neuroscience Center Core GrantP30NS047463 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVLISHOCK, JOHN T · 2003 to 2013
$5.0M
Extracellular Matrix Mediates Axonal Integrity Following Brain TraumaR01NS056247 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2007 to 2017
$3.4M
New Approaches to Axonal Protection After TBIR01NS057758 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI REEVES, THOMAS M. · 2007 to 2017
$3.3M
Matrix Metalloproteinases and Regenerative Plasticity Following Brain InjuryR01NS044372 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2002 to 2011
$2.9M
Matrix Metalloproteinases and Regenerative Plasticity Following Brain InjuryR56NS044372 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI PHILLIPS, LINDA L. · 2007 to 2007
$373k
NINDS NIH HHS NS-044372NINDS NIH HHS NS-056247NINDS NIH HHS NS-057758NINDS NIH HHS P30 NS047463NINDS NIH HHS R01 NS044372NINDS NIH HHS R01 NS057758NINDS NIH HHS R56 NS044372
6 · The paper itself

Abstract

This study documents the spatial and temporal expression of three structurally related chondroitin sulfated proteoglycans (CSPGs) during synaptic regeneration induced by brain injury. Using the unilateral entorhinal cortex (EC) lesion model of adaptive synaptogenesis, we documented mRNA and protein profiles of phosphacan and its two splice variants, full length receptor protein tyrosine phosphatase β (RPTPβ) and the short transmembrane receptor form (sRPTPβ), at 2, 7, and 15 days postlesion. We report that whole hippocampal sRPTPβ protein and mRNA are persistently elevated over the first two weeks after UEC. As predicted, this transmembrane family member was localized adjacent to synaptic sites in the deafferented neuropil and showed increased distribution over that zone following lesion. By contrast, whole hippocampal phosphacan protein was not elevated with deafferentation; however, its mRNA was increased during the period of sprouting and synapse formation (7d). When the zone of synaptic reorganization was sampled using molecular layer/granule cell (ML/GCL) enriched dissections, we observed an increase in phosphacan protein at 7d, concurrent with the observed hippocampal mRNA elevation. Immunohistochemistry also showed a shift in phosphacan distribution from granule cell bodies to the deafferented ML at 2 and 7d postlesion. Phosphacan and sRPTPβ were not colocalized with glial fibrillary acid protein (GFAP), suggesting that reactive astrocytes were not a major source of either proteoglycan. While transcript for the developmentally prominent full length RPTPβ was also increased at 2 and 15d, its protein was not detected in our adult samples. These results indicate that phosphacan and RPTPβ splice variants participate in both the acute degenerative and long-term regenerative phases of reactive synaptogenesis. These results suggest that increase in the transmembrane sRPTPβ tyrosine phosphatase activity is critical to this plasticity, and that local elevation of extracellular phosphacan influences dendritic organization during synaptogenesis.

Indexed as

AnimalsBlotting, WesternBrain InjuriesEntorhinal CortexHippocampusImmunohistochemistryMaleMicroscopy, ConfocalMicroscopy, Electron, TransmissionNeurogenesisNeuronal PlasticityProtein IsoformsRatsRats, Sprague-DawleyReceptor-Like Protein Tyrosine Phosphatases, Class 5Reverse Transcriptase Polymerase Chain ReactionProtein IsoformsReceptor-Like Protein Tyrosine Phosphatases, Class 5dentate gyrusentorhinal lesiongene expressionproteoglycansynaptic plasticity

Identifiers

PMID20014386
PMCPMC2889017
OpenAlexW2030341545

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.